ArriVent BioPharma, Inc. AVBP Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$166.31M-107% | -$80.49M-16.1% | ||
| -$3.03M— | —— | ||
| $12.52M+290% | $3.21M+258% | ||
| —— | -$751K— | ||
| $6.67M+4.5% | $6.38M+310% | ||
| $12.84M+977% | -$1.46M+84.9% | ||
| -$21K— | —— | ||
| -$160.59M-129% | -$70.21M-25.7% | ||
| $272.93M+40.6% | $194.16M+677% | ||
| $201.71M+11,772% | $1.7M-93.2% | ||
| -$71.23M+63.0% | -$192.47M— | ||
| $208.78M— | —— | ||
| $203.06M+8.8% | $186.58M— | ||
| -$28.75M— | —— | ||
| —— | -$751K— | ||
| -$21K— | —— | ||
| —— | $20K— | ||
| $12.84M+977% | -$1.46M+84.9% | ||
| $201.71M+11,772% | $1.7M— | ||
| —— | —— | ||
| -$21K— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ArriVent BioPharma, Inc. generate?
- ArriVent BioPharma, Inc. (AVBP) generated -$134.5M in operating cash flow over the trailing twelve months.
- Where does ArriVent BioPharma, Inc.'s cash flow data come from?
- Every line is extracted from ArriVent BioPharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.